home / stock / pavmz / pavmz news

PAVMZ News and Press, PAVmed Inc. Series Z Warrant From 03/31/20

Stock Information
Company Name: PAVmed Inc. Series Z Warrant
Stock Symbol: PAVMZ
Market: NASDAQ
Website: pavmed.com
Menu
PAVMZ PAVMZ Quote PAVMZ Short PAVMZ News PAVMZ Articles PAVMZ Message Board
Get PAVMZ Alerts

News, Short Squeeze, Breakout and More Instantly...
PAVMZ - PAVmed Receives $6.3 Million in Gross Proceeds from Completion of November 2019 Financing

NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has received $6.3 million in new gross proceeds from the prepayment of p...
PAVMZ - PAVmed to Hold Business Update Conference Call on April 9, 2020

NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the Company will report fourth quarter 2019 financial results after th...

PAVMZ - PAVmed Announces FDA 510(k) Re-submission for its CarpX(TM) Minimally Invasive Carpal Tunnel Device

Incorporates data from successful clinical safety study in which all patients met pre-specified safety and effectiveness endpoints NEW YORK, March 09, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differen...

PAVMZ - PAVmed Subsidiary Lucid Diagnostics Partners with Fred Hutchinson Cancer Research Center to Evaluate Barrett's Esophagus (BE) Progression Biomarkers Using EsoCheck(TM)

Lucid secures exclusive option to license biomarker technology to detect progression from nondysplastic to dysplastic BE using EsoCheck to allow curative ablation before deadly esophageal cancer develops NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (t...
PAVMZ - PAVmed Adds EsoCure(TM) Esophageal Ablation Device with Patented Caldus(TM) Technology to Commercial Product Pipeline

Disposable single-use device designed to provide safer, more efficient and cost-effective ablation of dysplastic Barrett’s Esophagus, complementing Lucid Diagnostics’ EsoGuard ™ and EsoCheck ™ products NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc...

PAVMZ - U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test

NEW YORK, Feb. 11, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the Company’s majority owned subsidiary, Lucid Diagnostics Inc. ...

PAVMZ - PAVmed Receives Formal Notification of Nasdaq Continued Listing Compliance

NEW YORK, Jan. 13, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has received formal notification from the Nasdaq Stock Market LLC (ȁ...
PAVMZ - PAVmed Subsidiary Lucid Diagnostics Announces Commercial Launch of EsoGuard Esophageal DNA Test

First commercially available DNA test designed to facilitate the diagnosis of Barrett’s Esophagus and related precursors to highly lethal form of esophageal cancer First patients to undergo testing today at gastroenterology center of excellence NEW YORK, Dec. 19, 2019 (GLOBE...

PAVMZ - PAVmed Provides Update on CarpX(TM) Clinical Safety Study

NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on its CarpX™ first-in-human (FIH) 510(k) clinical safety st...

PAVMZ - PAVmed Reports Third Quarter 2019 Financial Results and Provides Business Update

Conference call to be held on November 21, 2019 at 4:30 p.m. Eastern time NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) --   PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today r...
Previous 10 Next 10